Not applicableStudy completedNCT01459224What this trial is testingMELT - MRI Evaluation of Lymphoma TreatmentWho this might be right forLymphoma, Hodgkin University College, London 58
Testing effectiveness (Phase 2)Study completedNCT03586999What this trial is testingNivolumab With Standard of Care Chemotherapy for Peripheral T Cell LymphomasWho this might be right forPeripheral T Cell Lymphoma University of Colorado, Denver 18
Testing effectiveness (Phase 2)UnknownNCT01735604What this trial is testingGenetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to ChemotherapyWho this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more Chinese PLA General Hospital 50
Not applicableStudy completedNCT04902092What this trial is testingBrain Exercise and Addiction TrialWho this might be right forCannabis Use Disorder, ModerateCannabis Use Disorder, Severe Monash University 65
Not applicableUnknownNCT05343611What this trial is testingChocolate and Physical Exercise to Reduce Malnutrition in Pre-dementia Aged PeopleWho this might be right forDementiaDementia, MildDementia Moderate+4 more Massimo Venturelli, PhD 102
Not applicableStudy completedNCT03619993What this trial is testingPatient Preference for Pegfilgrastim (Neulasta®) Application FormsWho this might be right forNon Hodgkin LymphomaBreast Cancer iOMEDICO AG 404
Testing effectiveness (Phase 2)Ended earlyNCT00143884What this trial is testingStudy of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the BloodWho this might be right forLeukemiaLymphoma, Low-GradeLymphoma, Non-Hodgkin's+2 more University of Michigan Rogel Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT01564277What this trial is testingRasburicase and Allopurinol in Treating Patients With Hematologic MalignanciesWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+16 more Roswell Park Cancer Institute 24
Early research (Phase 1)Ended earlyNCT01300611What this trial is testingTXA127 in Enhancement of Engraftment in Adult Double Cord Blood TransplantationWho this might be right forDouble Cord Blood TransplantAcute Myelogenous LeukemiaMyelodysplastic Syndrome+6 more Tarix Pharmaceuticals 20
Early research (Phase 1)Ended earlyNCT00022971What this trial is testingCombination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic LeukemiaWho this might be right forDiffuse Large B-Cell LymphomaFollicular LymphomaChronic Lymphocytic Leukemia+2 more National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Very early researchEnded earlyNCT02070393What this trial is testingBreast-Sparing Proton Therapy for Hodgkin's DiseaseWho this might be right forHodgkins Disease Indiana University 3
Large-scale testing (Phase 3)Study completedNCT01938001What this trial is testingRituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)Who this might be right forLymphoma, Non-Hodgkin Celgene 358
Early research (Phase 1)Ended earlyNCT00471367What this trial is testingPhase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877Who this might be right forLymphomaNHLNon-Hodgkin Lymphoma AstraZeneca 44
Not applicableLooking for participantsNCT01788839What this trial is testingLongitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaWho this might be right forBreast CancerLymphomaHodgkin's Lymphoma Memorial Sloan Kettering Cancer Center 475
Testing effectiveness (Phase 2)Study completedNCT00850512What this trial is testingStudy to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) TherapyWho this might be right forDiffuse Large B-Cell Lymphoma University of Bologna 55
Testing effectiveness (Phase 2)Study completedNCT00726700What this trial is testingPegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin LymphomaWho this might be right forLymphoma Universität des Saarlandes 109
Testing effectiveness (Phase 2)Study completedNCT00783367What this trial is testingCombination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell LymphomasWho this might be right forFollicular LymphomaMarginal Zone B-Cell LymphomaMALT Lymphoma+4 more Abramson Cancer Center at Penn Medicine 50
Testing effectiveness (Phase 2)UnknownNCT02061800What this trial is testingCD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantWho this might be right forChronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more Diane George 14
Testing effectiveness (Phase 2)Study completedNCT00633594What this trial is testingRituximab, Lenalidomide, and Bortezomib in Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma SCRI Development Innovations, LLC 39